Robert  Camerlinck net worth and biography

Robert Camerlinck Biography and Net Worth

COO of Cano Health
Bob Camerlinck has been appointed Chief Operating Officer, overseeing the Company’s daily business operations and working closely with executive leadership to implement Cano Health’s strategy and drive sustained performance.

What is Robert Camerlinck's net worth?

The estimated net worth of Robert Camerlinck is at least $0.00 as of August 11th, 2023. Mr. Camerlinck owns 26,958,642 shares of Cano Health stock worth more than $0 as of April 27th. This net worth estimate does not reflect any other assets that Mr. Camerlinck may own. Additionally, Mr. Camerlinck receives an annual salary of $471,500.00 as COO at Cano Health. Learn More about Robert Camerlinck's net worth.

How old is Robert Camerlinck?

Mr. Camerlinck is currently 57 years old. There are 1 older executives and no younger executives at Cano Health. Learn More on Robert Camerlinck's age.

What is Robert Camerlinck's salary?

As the COO of Cano Health, Inc., Mr. Camerlinck earns $471,500.00 per year. Learn More on Robert Camerlinck's salary.

How do I contact Robert Camerlinck?

The corporate mailing address for Mr. Camerlinck and other Cano Health executives is 1601 WASHINGTON AVENUE SUITE 800, MIAMI BEACH FL, 33139. Cano Health can also be reached via phone at 855-226-6633 and via email at [email protected]. Learn More on Robert Camerlinck's contact information.

Has Robert Camerlinck been buying or selling shares of Cano Health?

Robert Camerlinck has not been actively trading shares of Cano Health over the course of the past ninety days. Most recently, Robert Camerlinck sold 30,646 shares of the business's stock in a transaction on Friday, August 11th. The shares were sold at an average price of $0.77, for a transaction totalling $23,597.42. Following the completion of the sale, the chief operating officer now directly owns 26,958,642 shares of the company's stock, valued at $20,758,154.34. Learn More on Robert Camerlinck's trading history.

Who are Cano Health's active insiders?

Cano Health's insider roster includes Richard Aguilar (Insider), Robert Camerlinck (COO), Marlow Hernandez (CEO), and Solomon Trujillo (Director). Learn More on Cano Health's active insiders.

Are insiders buying or selling shares of Cano Health?

During the last twelve months, insiders at the sold shares 19 times. They sold a total of 1,586,049 shares worth more than $3,579,882.45. The most recent insider tranaction occured on January, 31st when Major Shareholder Elliot Cooperstone sold 8,935 shares worth more than $23,141.65. Insiders at Cano Health own 13.9% of the company. Learn More about insider trades at Cano Health.

Information on this page was last updated on 1/31/2024.

Robert Camerlinck Insider Trading History at Cano Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2023Sell30,646$0.77$23,597.4226,958,642View SEC Filing Icon  
See Full Table

Robert Camerlinck Buying and Selling Activity at Cano Health

This chart shows Robert Camerlinck's buying and selling at Cano Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cano Health Company Overview

Cano Health logo
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $3.81
Low: $2.00
High: $9.31

2 Week Range

Now: N/A

Volume

159,142 shs

Average Volume

423,785 shs

Market Capitalization

$12.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.05